Standout Papers

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients W... 2018 2026 2020 2023 422
  1. Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors (2018)
    Jason J. Luke, Jeffrey M. Lemons et al. Journal of Clinical Oncology

Immediate Impact

9 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Regulation of the cGAS-STING Pathway
2025 Standout
Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Standout
2 intermediate papers

Works of J.M. Melotek being referenced

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors
2018 Standout

Author Peers

Author Last Decade Papers Cites
J.M. Melotek 274 311 535 369 27 864
Y.A. Abuodeh 241 139 544 504 36 1.1k
Iris Gluck 296 363 623 299 26 1.0k
D.A. Clump 299 359 445 399 46 1.1k
Thomas D. Shellenberger 220 184 361 292 19 997
Yi‐Jun Hua 377 486 372 326 34 923
Qiang Zhang 431 661 282 316 21 1.0k
Nicholas J Sanfilippo 408 80 390 399 32 951
John Showel 389 512 395 311 23 1.0k
Hale Başak Çağlar 171 192 193 452 40 765
Christine Ciunci 121 80 828 649 43 1.1k

All Works

Loading papers...

Rankless by CCL
2026